Correlation Between Emergent Biosolutions and Eli Lilly

Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Eli Lilly at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Eli Lilly into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Emergent Biosolutions and Eli Lilly and, you can compare the effects of market volatilities on Emergent Biosolutions and Eli Lilly and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Eli Lilly. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Eli Lilly.

Diversification Opportunities for Emergent Biosolutions and Eli Lilly

-0.42

Correlation Coefficient

Emergent Biosolutions  Eli Lilly

Very good diversification

The 3 months correlation between Emergent and Eli is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Eli Lilly and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eli Lilly and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Eli Lilly. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eli Lilly has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Eli Lilly go up and down completely randomly.

Pair Corralation between Emergent Biosolutions and Eli Lilly

Considering the 90-day investment horizon Emergent Biosolutions is expected to generate 3.46 times more return on investment than Eli Lilly. However, Emergent Biosolutions is 3.46 times more volatile than Eli Lilly and. It trades about 0.08 of its potential returns per unit of risk. Eli Lilly and is currently generating about -0.15 per unit of risk. If you would invest  831.00  in Emergent Biosolutions on August 30, 2024 and sell it today you would earn a total of  180.00  from holding Emergent Biosolutions or generate 21.66% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Emergent Biosolutions  vs.  Eli Lilly and

Emergent Biosolutions

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Emergent Biosolutions are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental drivers, Emergent Biosolutions unveiled solid returns over the last few months and may actually be approaching a breakup point.

Eli Lilly

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Eli Lilly and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Emergent Biosolutions and Eli Lilly

The main advantage of trading using opposite Emergent Biosolutions and Eli Lilly positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Eli Lilly can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eli Lilly will offset losses from the drop in Eli Lilly's long position.

The idea behind Emergent Biosolutions and Eli Lilly and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.